Spin-density-wave transition of (TMTSF)2_2PF6_6 at high magnetic fields

The transverse magnetoresistance of the Bechgaard salt (TMTSF)$_2$PF$_6$ has been measured for various pressures, with the field up to 24 T parallel to the lowest conductivity direction c$^{\ast}$. A quadratic behavior is observed in the magnetic field dependence of the spin-density-wave (SDW) transition temperature $T_{\rm {SDW}}$. With increasing pressure, $T_{\rm {SDW}}$ decreases and the coefficient of the quadratic term increases. These results are consistent with the prediction of the mean-field theory based on the nesting of the quasi one-dimensional Fermi surface. Using a mean field theory, $T_{\rm {SDW}}$ for the perfect nesting case is estimated as about 16 K. This means that even at ambient pressure where $T_{\rm {SDW}}$ is 12 K, the SDW phase of (TMTSF)$_2$PF$_6$ is substantially suppressed by the two-dimensionality of the system.Comment: 11pages,6figures(EPS), accepted for publication in PR

SDW and FISDW transition of (TMTSF)2_2ClO4_4 at high magnetic fields

The magnetic field dependence of the SDW transition in (TMTSF)$_2$ClO$_4$ for various anion cooling rates has been measured, with the field up to 27T parallel to the lowest conductivity direction $c^{\ast}$. For quenched (TMTSF)$_2$ClO$_4$, the SDW transition temperature $T_{\rm {SDW}}$ increases from 4.5K in zero field up to 8.4K at 27T. A quadratic behavior is observed below 18T, followed by a saturation behavior. These results are consistent with the prediction of the mean-field theory. From these behaviors, $T_{\rm {SDW}}$ is estimated as $T_{\rm {SDW_0}}$=13.5K for the perfect nesting case. This indicates that the SDW phase in quenched (TMTSF)$_2$ClO$_4$, where $T_{\rm {SDW}}$ is less than 6K, is strongly suppressed by the two-dimensionality of the system. In the intermediate cooled state in which the SDW phase does not appear in zero field, the transition temperature for the field-induced SDW shows a quadratic behavior above 12T and there is no saturation behavior even at 27T, in contrast to the FISDW phase in the relaxed state. This behavior can probably be attributed to the difference of the dimerized gap due to anion ordering.Comment: 4pages,5figures(EPS), accepted for publication in PR

User Experiences of Development of Dependence on the Synthetic Cannabinoids, 5f-AKB48 and 5F-PB-22, and Subsequent Withdrawal Syndromes

Emergence of synthetic cannabinoids (SCBs) in herbal smoking mixtures is a public health concern. New SCB’s such as 5f-AKB48 and 5F-PB-22 have been detected in French seizures and in sudden death post mortems in the US. The aim was to describe development of dependence on herbal smoking mixtures containing the SCB’s, 5f-AKB48 and 5F-PB-22 and subsequent withdrawal syndromes. Dependent users of herbal smoking mixtures known to contain the SCB’s 5f-AKB48 and 5F-PB-22 with an average Severity of Dependence Score (SDS) of 13 were interviewed using a structured guide (three males/three females). Narratives were analysed using the Empirical Phenomenological Psychological (EPP) five step method. Six themes with 68 categories emerged from the analysis. Themes are illustrated as 1) Networks and Product Availability; 2) Drivers and Motives for Use; 3) Effect and Pathways toward Dependence; 4) Poly Substance Use and Comparisons to Natural Cannabis; 5) Dependence and Withdrawal and 6) Self-detoxification Attempts. Two higher levels of abstraction above these theme-levels emerged from the data, with sole use of herbal smoking mixtures containing 5f-AKB48 and 5F-PB-22 centering on the interplay between intense cravings, compulsive all-consuming seeking, use and re-dose behaviours, and fear of the psychiatric and self-harms caused when in withdrawal. This is the first study describing dependence and withdrawal experiences in users dependent on 5f-AKB48 and 5F-PB-22. Given the potential for adverse psychiatric and physical consequences of dependent use, further development of specific clinical responses and clinical research around toxicity and withdrawal severity are warranted

Anti-HBs antibodies produced after liver transplantation: From the donor or the recipient? [5] (multiple letters)

link_to_subscribed_fulltex